GLS - MUSKEGON
1. Target Overview & Investment Thesis
GLS - MUSKEGON is a 31-bed under-performing / distressed in MUSKEGON, MI with $3.5M in net patient revenue and a -15.7% operating margin. The hospital serves a payer mix of 40.4% Medicare, 10.3% Medicaid, and 49.3% commercial.
Thesis: Turnaround. Our ML models identify $274K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.7% to -8.0% (+775bps).
| Net Revenue HCRIS | $3.5M |
| Current EBITDA COMPUTED | $-556K |
| Operating Margin COMPUTED | -15.7% |
| Occupancy HCRIS | 57.0% |
| Revenue / Bed COMPUTED | $114K |
| Net-to-Gross HCRIS | 31.0% |
| Distress Probability ML | 50.1% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -15.7% places it below the state median. Among 71 size-comparable peers (16-62 beds), the median margin is -1.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (16-62), prioritizing same-state peers. 71 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GLS - MUSKEGON (Target) | MI | 31 | $3.5M | -15.7% |
| TRINITY HEALTH LIVINGSTON | MI | 42 | $200.4M | 15.2% |
| MYMICHIGAN MEDICAL CENTER ALMA | MI | 49 | $142.2M | -5.9% |
| SPECTRUM HEALTH UNITED MEMORIA | MI | 45 | $129.4M | 9.7% |
| DICKINSON COUNTY HEALTHCARE SY | MI | 49 | $126.3M | -4.7% |
| PROMEDICA HICKMAN HOSPITAL | MI | 58 | $124.7M | 5.5% |
| MUNSON HEALTHCARE CADILLAC HOS | MI | 49 | $122.7M | 1.0% |
| MCLAREN CENTRAL MICHIGAN | MI | 49 | $118.9M | -35.3% |
| SPECTRUM HEALTH GERBER | MI | 25 | $116.2M | 16.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $274K (775bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Denial Rate Reduction | 12.0% | 6.5% | $76K | +216bp | 12mo |
| Net Collection Rate | 93.5% | 97.0% | $74K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $71K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $43K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +27bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-556K |
| + RCM Uplift | +$274K |
| Pro Forma EBITDA | $-282K |
| Current Margin | -15.7% |
| Pro Forma Margin | -8.0% |
| WC Released (1x) | $136K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-855K | $-929K | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-855K | $-1.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-770K | $-674K | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-770K | $-962K | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-941K | $-2.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-941K | $-2.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 50.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 71 hospitals with 16-62 beds
- Same-state prioritization (n=72)
- Comp margins: P25=-10.5% / P50=-1.4% / P75=9.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.